Peptide Initiative

Dosing protocol · Cosmetic

Myristoyl Pentapeptide-17 dosing & administration

Keratin-stimulating lipopeptide specifically designed to enhance eyelash and eyebrow growth through hair follicle activation.

Suggested dose

0.001 % – 0.1 %

Once or twice daily to lash line / browsFrequency
TopicalRoute
Ongoing/indefiniteCycle length

Dosing

How much Myristoyl Pentapeptide-17 do I take?

Topical

Topical: Applied onto the skin as a cream, gel, or lotion — it works mainly where you put it.

Bioavailability Local — acts mainly at the skin; little reaches the bloodstream.

  • 0.001-0.1% in finished serum (supplied as a 0.1% / 1000 ppm active solution)

    Frequency
    Once or twice daily to lash line / brows
    Duration
    8-16 weeks for visible lash effect

    Cosmetic lash/brow active applied to the lash line; typical eye-area use concentrations and the 1000 ppm supplier solution define the formulation dose . Topical only; not dosed systemically.

Timing

Best time to take

Apply Myristoyl Pentapeptide-17 to clean, dry skin. For best results, use consistently at the same time(s) each day. Evening application is often preferred to allow overnight absorption, unless otherwise directed.

With food?

As a topical product, Myristoyl Pentapeptide-17 is not affected by food intake. Apply to clean skin and allow adequate absorption time before covering the area.

If stacking

Myristoyl Pentapeptide-17 should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.

Adjusting your dose

Increase if

  • You've tolerated the current dose for the recommended period without significant side effects
  • Therapeutic goals haven't been met at the current dose level
  • Your healthcare provider recommends dose escalation based on your response
  • Lab work or clinical assessments support a higher dose

Decrease if

  • Side effects are bothersome or impacting daily life despite management strategies
  • You experience any signs of an adverse reaction
  • Lab results indicate the need for dose reduction
  • Your healthcare provider recommends a lower dose based on your response

Signs of right dose

  • Therapeutic goals being met with minimal side effects
  • Stable and consistent response to treatment
  • Lab values or clinical markers trending in the right direction
  • Good tolerance with manageable or absent side effects

Administration

How do I use Myristoyl Pentapeptide-17?

Reconstitution

What you need

  • Myristoyl Pentapeptide-17 in its prescribed form
  • Clean, dry storage container
  • Measuring device if applicable (oral syringe, measuring cup)
  • Calendar or reminder app for dosing schedule

Injection

Route

Myristoyl Pentapeptide-17 is administered Topical—no injection required

Best sites

  • Not applicable—this is not an injectable formulation

Storage

Before reconstitution

Store Myristoyl Pentapeptide-17 in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.

After reconstitution

Once reconstituted, Myristoyl Pentapeptide-17 should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.

Signs of degradation — discard the vial

  • Solution appears cloudy, discolored, or contains visible particles (should be clear)
  • Product has been exposed to temperatures outside the recommended storage range
  • Product has been frozen (unless specifically designed for freeze-thaw stability)
  • Expiration date has passed or reconstituted solution has exceeded its use-by date
  • Unusual odor, color change, or visible contamination

Sample daily schedule

  • As prescribed (once daily)

    As prescribed by your healthcare provider injection

    Site: Topical—rotate sites if applicable

    Maintain a consistent schedule for optimal results with Myristoyl Pentapeptide-17. Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.

Safety

Is Myristoyl Pentapeptide-17 safe?

Side effects

Commonly reported: Mild Tingling at Lash Line, Temporary Eyelid Dryness, Product Residue Buildup, Lash Shedding During Initial Phase

Less common: Periorbital Sensitivity

Serious side effects

  • Allergic Contact Reaction
  • Lipid Peroxidation and Oxidative Stress

Stop and seek help if

  • Severe or worsening side effects that don't improve with dose adjustment or supportive care
  • Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
  • Your healthcare provider recommends discontinuation based on your clinical response
  • Development of any new medical condition that may be contraindicated with Myristoyl Pentapeptide-17
  • Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
  • Abnormal lab results or clinical markers that suggest adverse effects

Myristoyl Pentapeptide-17 should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.

Flagged pairings

  • Prostaglandin Analogs (bimatoprost, latanoprost) — Use with caution—discuss with your healthcare provider.
  • High-concentration Retinoids near the eye — Use with caution—discuss with your healthcare provider.
  • Waterproof Mascara (directly over wet serum) — Use with caution—discuss with your healthcare provider.

Published research

What the studies show

  • Limited human trials
  • Research compound
  1. Open clinical trial evaluating efficacy of a peptide and glycosaminoglycan-based eyelash enhancer

    Fernandez-Gonzalez P, et al. · 2024PubMed

    A 12-week clinical trial of an eyelash growth enhancer showed dramatic improvements: lash length increased 8.3%, number increased 5%, width increased 10.1%, volume surged 14.1%. Patient satisfaction reached 84.33%.

  2. AP collagen peptides promote hair growth by activating the GSK-3β/β-catenin pathway

    Lee JO, et al. · 2024PubMed

    AP collagen peptides promoted hair growth by activating the GSK-3β/β-catenin pathway, increasing follicle elongation and stimulating new hair shaft induction in mice. Hair thickness and amino acid content improved significantly.

  3. Low molecular weight collagen peptide promotes hair growth by activating Wnt/GSK-3β/β-catenin signaling

    Kim Y, et al. · 2024PubMed

    Low molecular weight collagen peptides activated the Wnt/β-catenin pathway, promoting hair growth through dermal papilla cell activation. Oral administration to mice significantly stimulated hair growth with elevated gene expression.

  4. Hair growth promoting activity of keratin extract applied topically

    Akanda MR, et al. · 2017PubMed

    Keratin extract topically applied promoted hair growth by inducing the anagen growth phase in telogenic mice, increasing follicle number. More than 90% cell viability was maintained, proving biocompatibility.

  5. A new strategy to modulate alopecia using a combination of two specific and unique ingredients

    Loing E, Lachance R, Ollier V, et al. · 2013PubMed

    A placebo-controlled trial of peptide plus plant extract increased anagen hair 13%, decreased telogen hair 29%, raised anagen/telogen ratio 46% after 4 months. Results differed dramatically from placebo.

  6. Myristoyl Pentapeptide-17 (SymPeptide 226EL) cosmetic ingredient profile

    Cosmetic Ingredients Guide · 2024ci.guide

    Lipo-oligopeptide eyelash enhancer supplied as a 1000 ppm (0.1%) bioavailable solution; used in eye-area lash/brow serums at low finished-product concentrations.

Head to head

Myristoyl Pentapeptide-17 compared

Want the full picture?

The complete Myristoyl Pentapeptide-17 research profile: mechanism of action, clinical studies, effectiveness timeline, and FAQ.